Related Experiment Video

Updated: Jun 22, 2026

A Combined 3D Tissue Engineered In Vitro/In Silico Lung Tumor Model for Predicting Drug Effectiveness in Specific Mutational Backgrounds
13:34

A Combined 3D Tissue Engineered In Vitro/In Silico Lung Tumor Model for Predicting Drug Effectiveness in Specific Mutational Backgrounds

Published on: April 6, 2016

Epidermal growth factor receptor signaling in liver cell proliferation and apoptosis

Roland Reinehr1, Dieter Häussinger

  • 1Clinic for Gastroenterology, Hepatology and Infectiology, University Hospital Düsseldorf, Heinrich Heine University, D-40225 Düsseldorf, Germany.

Biological Chemistry
|June 30, 2009
PubMed

Insights

Epidermal growth factor receptor (EGFR) signaling drives liver cell proliferation and death, crucial for hepatic regeneration. Its interaction with CD95 death receptor signaling depends on cellular context.

Area of Science:

  • Hepatology
  • Molecular Biology
  • Cell Signaling

Background:

  • Epidermal growth factor receptor (EGFR) signaling is implicated in liver cell proliferation and apoptosis.
  • EGFR plays a role in regulating hepatic regeneration.

Purpose of the Study:

  • To summarize recent findings on molecular mechanisms of EGFR-mediated cell proliferation and apoptosis.
  • To highlight the interplay between EGFR and CD95 (Fas, APO-1) death receptor signaling in the liver.

Main Methods:

  • Review of recent evidence on EGFR signaling pathways.
  • Analysis of molecular mechanisms governing liver cell proliferation and apoptosis.
  • Investigation of the interaction between EGFR and CD95 signaling.

Main Results:

  • EGFR signaling influences both liver cell proliferation and apoptotic cell death.
  • The interplay between EGFR and CD95 signaling is context-dependent.
  • Liver cell type influences the outcome of EGFR and CD95 signaling.

Conclusions:

  • EGFR is a key regulator of hepatic regeneration through its control of cell proliferation and apoptosis.
  • The functional outcome of EGFR signaling in the liver is modulated by the CD95 death receptor pathway.
  • Understanding these signaling networks is vital for comprehending liver repair mechanisms.

More Related Videos

Isolation of CD133+ Liver Stem Cells for Clonal Expansion12:06

Isolation of CD133+ Liver Stem Cells for Clonal Expansion

Published on: October 10, 2011

Related Concept Videos

Liver Regeneration01:24

Liver Regeneration

The liver is an important organ in vertebrates that plays an essential role in metabolism. It is also responsible for storing and redistributing nutrients such as carbohydrates, fats, and vitamins in the body. Additionally, the liver releases bile salts which are critical for digesting food and eliminating toxic metabolites from the body.
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are large...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...